GliSODin (The Antioxidant Catalyst) 100 mg Fact Sheet
Neil E. Levin, CCN, DANLA
01/31/05
Likely Users: People with exposure oxidizing chemicals; People wanting to increase their body’s production of antioxidants.
Key Ingredient (S): SOD (Superoxide Dismutase antioxidant enzyme) from melons Organic Wheat Grass leaf
Main Product Features: Patented, clinically tested form of SOD to ensure absorbability; Protects cell mitochondria from oxidative stress that leads to genetic damage the cells; Reduces markers of cellular oxidative damage in the blood; May increase the body’s production of important antioxidants including SOD, Glutathione and Catalase.
Other Important Issues: This product contains wheat protein as an aid to protecting the SOD and increasing its absorption. The base of organic wheat grass synergistically provides additional, naturally occurring levels of SOD and other nutrients, though this additional SOD is not well absorbed.
Amount and how to use: One to three capsules a day, preferably between meals. If taken at mealtime avoid taking non-chelated (alkaline) forms of minerals at the same meal and take this capsule at the beginning of the meal to speed its transit time through the stomach and minimize exposure to alkaline foods and supplements that may cause the capsule to break down prematurely. That could potentially reduce the effectiveness of this form of SOD. The coating is designed to survive stomach acid and dissolve in the more alkaline conditions of the small intestine.
Synergists: Alpha Lipoic Acid, EGCg Green Tea Extract, Whey Protein Isolate, Selenium, NAC, Vitamin C, other Antioxidants.
Cautions: Contains wheat and wheat proteins, should not be used by people who are gluten-intolerant. Gluten intolerance may manifest with neurological, not abdominal symptoms, so please consider having a gluten intolerance test if you do have any neurological problems. Please notify your physician about your supplement use if you are using any drugs!
Reference: Free Radic Res. 2004 Sep;38(9):927-32. Influence of an orally effective SOD on hyperbaric oxygen-related cell damage. Muth CM, Glenz Y, Klaus M, Radermacher P, Speit G, Leverve X. Sektion Anasthesiologische Pathophysiologie und Verfahrensentwicklung, Universitatsklinikum Ulm, D-89073 Ulm, Germany. PMID: 15621710 [PubMed - in process] |
1-800-418-4842
